In the News: Seven Biopharma Trends to Watch in 2022

Dr. Christina Smolke provides visionary insight on the trends shaping biopharma in 2022. Against a backdrop of skeptical news about the synthetic biology field, Antheia weighs in about the great potential for 2022 and beyond: “Synthetic biology is on track to achieving full-scale manufacturing across diverse applications, and is no longer just an academic enterprise,” said Dr. Smolke. “It has become a booming industry with real-world implications, and this trend will continue into 2022.” Read more to learn about how biopharma is reshaping the future here.